Rheumatology Advance Access originally published online on September 20, 2004
Rheumatology 2005 44(1):89-94; doi:10.1093/rheumatology/keh407
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology Vol. 44 No. 1 © British Society for Rheumatology 2004; all rights reserved
PAPER |
Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjögren's syndrome
Departments of Autoimmune Diseases and 1 Immunology, Department of Medicine, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, School of Medicine, University of Barcelona, Barcelona, Spain.
Correspondence to: M. Ramos-Casals, Servei de Malalties Autoimmunes, Hospital Clínic, C/Villarroel, 170, 08036-Barcelona, Spain. E-mail: mramos{at}clinic.ub.es
Objective. To analyse the prevalence and clinical significance of hypocomplementaemia in a large series of patients with primary Sjögren's syndrome (SS), focusing on the association of low complement levels with clinical manifestations, immunological features, lymphoproliferative disorders and mortality.
Methods. Complement determinations (C3 and C4 levels, CH50 activity) were made in 336 consecutive patients with primary SS (313 women and 23 men, mean age 58.5 yr). We also analysed complement levels in 46 patients with SS associated with hepatitis C virus (HCV) infection and 184 with HCV-related cryoglobulinaemia as control groups.
Results. Hypocomplementaemia was detected in 81 (24%) of patients with primary SS, low CH50 being detected in 51 (15%), low C3 values in 42 (12%) and low C4 values in 39 (12%). In the multivariate analysis, patients with low C4 levels showed a higher prevalence of peripheral neuropathy, cutaneous vasculitis, RF, cryoglobulins and lymphoma compared with those with normal C4 levels. The analysis of the 218 SS patients followed prospectively since 1994 showed a lower probability of survival in patients with hypocomplementaemia (with low C3, C4 or CH50 levels) at protocol entry. SS-HCV patients presented a higher frequency of hypocomplementaemia than patients with primary SS (76 vs 24%, P< 0.001); nine (20%) of these patients had persistent, unquantifiable complement levels.
Conclusion. Hypocomplementaemia is closely associated with systemic expression and adverse outcomes (lymphoma development and death) in patients with primary SS. Our results support the inclusion of complement determination at diagnosis as a predictor of the outcome of patients with primary SS and its routine determination in the clinical follow-up.
KEY WORDS: Hypocomplementaemia, Complement, Lymphoma, Sjögren's syndrome, HCV, Cryoglobulinaemia
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. RAMOS-CASALS, S. MUNOZ, F. MEDINA, L.-J. JARA, J. ROSAS, J. CALVO-ALEN, P. BRITO-ZERON, X. FORNS, J.-M. SANCHEZ-TAPIAS, and for the HISPAMEC Study Group Systemic Autoimmune Diseases in Patients with Hepatitis C Virus Infection: Characterization of 1020 Cases (The HISPAMEC Registry) J Rheumatol, July 1, 2009; 36(7): 1442 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Doi, T Matsushita, N Isobe, T Matsuoka, M Minohara, H Ochi, and J. Kira Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody Multiple Sclerosis, March 1, 2009; 15(3): 304 - 310. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Q. Nguyen, H. Kim, J. G. Cornelius, and A. B. Peck Development of Sjogren's Syndrome in Nonobese Diabetic-Derived Autoimmune-Prone C57BL/6.NOD-Aec1Aec2 Mice Is Dependent on Complement Component-3 J. Immunol., August 15, 2007; 179(4): 2318 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Koch, C. E. Jordan, and J. L. Platt Complement-Dependent Control of Teratoma Formation by Embryonic Stem Cells J. Immunol., October 1, 2006; 177(7): 4803 - 4809. [Abstract] [Full Text] [PDF]
|
|